⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16280747 | 0.73 | — | — | |
| SCHEMBL2150547 | 0.72 | — | — | |
| SCHEMBL14814664 | 0.72 | — | — | |
| SCHEMBL2836 | 0.70 | — | — | |
| SCHEMBL3887820 | 0.67 | — | — | |
| SCHEMBL8762326 | 0.67 | — | — | |
| SCHEMBL37444 | 0.67 | — | — | |
| SCHEMBL1766730 | 0.67 | — | — | |
| SCHEMBL29065621 | 0.67 | — | — | |
| SCHEMBL7992175 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4233928-A2 | NANORESERVOIRS | Université de Liège (BE) | 2023-08-30 | — | — | EP | disclosed |
| EP-3562513-B1 | NANORESERVOIRS | UNIV LIEGE (BE) | 2023-08-16 | — | — | EP | disclosed |
| US-11541129-B2 | Nanoreservoir coated medical devices, biomaterials, and bioprosthetics | Université de Liège (BE) | 2023-01-03 | — | — | US | disclosed |
| US-11052160-B2 | Selective delivery molecules and methods of use | AVELAS BIOSCIENCES, INC. (US) | 2021-07-06 | — | — | US | disclosed |
| US-20210079039-A1 | COMPOSITIONS AND METHODS FOR THE SELECTIVE DELIVERY OF THERAPEUTIC AND IMAGING AGENTS | AVELAS ACQUISITION CORPORATION | 2021-03-18 | — | — | US | disclosed |
| US-20200376013-A1 | SELECTIVE DRUG DELIVERY COMPOSITIONS AND METHODS OF USE | AVELAS BIOSCIENCES, INC. | 2020-12-03 | — | — | US | disclosed |
| US-20200085970-A1 | NANORESERVOIRS | Université de Liège (BE) | 2020-03-19 | — | — | US | disclosed |
| US-10570178-B2 | Selective delivery molecules and methods of use | AVELAS BIOSCIENCES, INC. (US) | 2020-02-25 | — | — | US | disclosed |
| US-20190151481-A1 | SELECTIVE DELIVERY MOLECULES AND METHODS OF USE | AVELAS ACQUISITION CORPORATION | 2019-05-23 | — | — | US | disclosed |
| US-20190119327-A1 | SELECTIVE DELIVERY MOLECULES AND METHODS OF USE | AVELAS ACQUISITION CORPORATION | 2019-04-25 | — | — | US | disclosed |
| US-20160152670-A1 | SELECTIVE DELIVERY MOLECULES AND METHODS OF USE | AVELAS ACQUISITION CORPORATION | 2016-06-02 | — | — | US | disclosed |
| US-20160082119-A1 | SELECTIVE DRUG DELIVERY COMPOSITIONS AND METHODS OF USE | AVELAS BIOSCIENCES, INC. | 2016-03-24 | — | — | US | disclosed |
| US-9278144-B2 | Selective delivery molecules and methods of use | AVELAS BIOSCIENCES, INC. (US) | 2016-03-08 | — | — | US | disclosed |
| US-20150359908-A1 | SELECTIVE DELIVERY MOLECULES AND METHODS OF USE | AVELAS ACQUISITION CORPORATION | 2015-12-17 | — | — | US | disclosed |
| US-20150031852-A1 | SELECTIVE DELIVERY MOLECULES AND METHODS OF USE | AVELAS BIOSCIENCES, INC. (US) | 2015-01-29 | — | — | US | disclosed |
| US-8859705-B2 | Hydrogel tissue adhesive having decreased gelation time and decreased degradation time | ACTAMAX SURGICAL MATERIALS LLC (US) | 2014-10-14 | — | — | US | disclosed |
| EP-2256153-B1 | HYDROPHILIC FILM | MITSUI CHEMICALS INC (JP) | 2014-06-25 | — | — | EP | disclosed |
| US-20140142063-A1 | HYDROGEL TISSUE ADHESIVE HAVING DECREASED GELATION TIME AND DECREASED DEGRADATION TIME | ACTAMAX SURGICAL MATERIALS, LLC (US) | 2014-05-22 | — | — | US | disclosed |
| US-20110008630-A1 | HYDROPHILIC FILM | MITSUI CHEMICALS, INC. (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-2256153-A1 | HYDROPHILIC FILM | Mitsui Chemicals, Inc. (JP) | 2010-12-01 | — | — | EP | disclosed |